Low HER2 Breast Cancer: Definition & Future Plans for Management
Time: 8:30 am
day: Day Two
Details:
• Navigating clinical development for the treatment of patients with HER2-expressing solid tumors, including HER2-low tumors
• Delving into latest results and future directions
Speakers:
Edith A. Perez, MD is an internationally recognized translational researcher and cancer specialist, Chief Medical Officer of Bolt Therapeutics, Inc., Professor of Medicine at Mayo Clinic, and Director of the Mayo Clinic Breast Cancer Translational Genomics Program. Dr. Perez is known for her strategic vision in designing innovative clinical trials, her passion for patient care,…Read more